Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific

Alice Arapshian1, Silvina Bertran, Yuvarani S Kuppumbatti

  • 1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029-6574, USA. aa74ny@yahoo.com

Molecular Cancer
|April 29, 2004
PubMed
Abstract

Insights

Cellular retinol binding protein I (CRBP) is epigenetically silenced by DNA hypermethylation in breast cancer. This conserved mechanism contributes to tumor progression and may be linked to specific oncogenes.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cellular retinol binding protein I (CRBP) gene downregulation is observed in human breast cancers and mouse models.
  • CRBP downregulation is implicated in breast tumor progression.
  • The epigenetic mechanisms driving CRBP silencing in cancer remain largely unknown.

Purpose of the Study:

  • To investigate the hypothesis that CRBP is epigenetically silenced through DNA hypermethylation in human and mouse breast cancer.
  • To determine the relationship between CRBP hypermethylation and CRBP expression.
  • To explore potential therapeutic strategies for reversing CRBP silencing.

Main Methods:

  • Bisulfite sequencing of the CRBP gene in human breast cancer cell lines and mouse mammary tumor cell lines.
  • Treatment with 5-azacytidine (DNA methyltransferase inhibitor) and trichostatin A (histone deacetylase inhibitor).
  • Southern blot analysis of human breast cancer specimens.

Main Results:

  • CRBP hypermethylation was inversely correlated with CRBP expression in most human breast cancer cell lines.
  • 5-azacytidine treatment restored CRBP expression, confirming DNA hypermethylation as a cause of silencing.
  • CRBP hypermethylation and silencing were observed in MMTV-Myc mouse models, suggesting an oncogene-specific event.

Conclusions:

  • CRBP hypermethylation is a conserved and primary mechanism for CRBP gene silencing in breast cancer.
  • CRBP silencing in human breast cancer may be associated with specific oncogenic signatures.
  • Targeting epigenetic modifications offers potential therapeutic avenues for breast cancer treatment.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...